Member Info for Indiscipline

Don't think the market will react bad at all if he has options. CF has brokerage background so will do it intelligently.
Key is we have the key Challenge trial team. Cash from this can grow other areas of the business and hit our bottom line in a major way.

We have the potential to be a true services heavyweight. CF not talking of selling unless for a serious premium. The prize now is way too big to give up.

PS Numpty Adrian's eyes are beautiful. Specially in the setting of our Labs.

Looks like masses going on behind the scenes.

Remember he is putting together the Company testing deals for Quotient. He said they were progressing nicely.
One thousand a day would give us around £10-12 mil in profit.

Imutex sale or spin off.

And Wildfire and his team were not brought infrom a £20billion testing conglomerate because he loves Adrian's eyes.
Challenger space is hotting up with regard Covid and outside of Covid.

The guy is known as the flying virologist because he oversees multiple tests during a day for different pharma's.
He's the guy in this area CF knew it and had to have him. The other Pharma's know he is the guy to create their tests succesfully.
That RNS was seismic forget about the share price off the news.

The Bass rule is really all about the amplifier and the pedal to make the most funky sound ala Peter Hook.

Hope that helps.

Pick which multiple you like in the "( two, three or four) hundred million dollar question?"

In the Proactive interview he promised news by June inventory wise. Another failed promise to add to his litany of failed promises. The £10 mil trading deal being his magnus opus "that was in that company's interest to deliver us revenues as high as possible".

Investors for six months lived the dream, now they live the nightmare. So many of us blindsided by JD's promises.
We lost some really good guys from this board and stock. Its a damn shame.

If he was honest with people they would have respect for him. It is not easy what he is attempting to do... but bull5hit dropped from his lips faster than from a cow's ar5e. "Within three - five years years we can be a multi billion pound company. We can be as big as Tradedesk".

He could be right if the technology is bought by a billion pound company.

Those are round about the numbers CF has been looking at.

Options in a small company that will multiply higher are damn valuable.

Unlike us, he knows exactly what's on the table - he obviously liked what he saw. Saying that CF is already bagging business just a hell of a lot more to be announced soon.

We got a range of resistances between the 15p-16p zone on a daily and weekly chart.

News which should not be that long away now will blast through it. Also important to remember the longer the stock stays in an area the bigger the catapult out of it as it builds up energy.

Fundamentally and technically we are doing very well here. The sector we are in is likely in a secular uptrend for a few years as it has been horrifically under-invested in. This should set the tone for one hell of a re-rate.

This is the reason CF has stopped talking of selling before Autumn because the figures are coming through and when he sees a Goldmine he wants to stay in it for as long as possible to pick as many nuggets as he can get his hands on. We got a serious CEO with seriously large opportunities available to him.

Elmer Hardwood in Reminisces of a stock operator" told Old Turkey a rich old trader after he gave him a tip this : "Well now is the time to take your profit and get in again on the next dip. I have just sold every share I own."

Mr. Partridg

e shook his head regretfully "I'm obliged to you my dear boy for recommending that stock. But, I couldn't think of selling it.

Hardwood: Why Not?

Partridge; "Why this is a bull market. If I sold my stock I would lose my position. And when you are as old as I you learn that is something nobody can afford."

Livermore states: "It was a long step forward in my trading education when I learnt that the real money was not made in the individual fluctuations but sizing the market and its trend....It was never my thinking that made the big money for me but my sitting. Got that!

The old boy was rich because he stuck with the trend and let the market do it's business. Pharma is getting hot it's in a secular uptrend. A top pharma services company can power ahead now. Pharmas are digging for gold and we will sell the picks and shovels.

One of the takeaways from the presentation was he is knocking out a deal every week. Even if they are in 300k-750k region doing it with such regularity is going to start hitting our bottom line in a major way.

We are becoming an extension of these companies a natural addition to their work. When CF started stating the regularity of these deals in particular I got very excited. It is early days, but he is running hard.

Small to mid level pharmas are desperate for the various info on the database. Streamlines their tests, saves money and time.

It also serves to show the depth of knowledge we have, which advertises our strength, when coming to sell our ancillary services in other areas. Which is hugely valuable to us.

We are looking like the big dog in the service industry, now.

I have a feeling that when it comes to all matters it's best to look at CF, not as a hot knife through butter, more a blowtorch through butter.

Always please don't mention BATM I sold at 20p. Mentioning them is painful.

Looks like the decks have been clearing. Glad to see that go through.
Tuesday looked like the capitulation sales.

There were some decent buys shown on Tuesday from the previous day so the stock is being moved on.
The presentations kick in. I think CF can and is really moving forward now.

That's precisely Imutex without the other vaccines and services.

That's precisely Imutex without the other vaccines and services.

He could have pumped like crazy, said the truth.

If we get around 500 to 600 mil, our share price pops three times at least, with 50% share. Then add in flu vaccine and Prep biopharm. It will all be monetised. As will all the other opportunities that CF has here.

If we are the top services firm from Phase 1-3 offerring a complete package, which we can be, imagine the contracts we can secure. Along with it we are have the database to provide our clients further aid in their work. CF bought brilliantly here.

Been studied that a stock only really starts popping when above the 70 line.
Masses of head room to go.

Secondly using it on a daily RSI means you can sell and the stock can gap way higher.
If you are using RSI go weekly. We are in a cyclical trend selling now is a bad move to try and buy back in cheaper.
Read reminisces of a Stock Operator and you will get the importance of not selling the trend.

In previous answer highly paid Professionals will sue the ar5e off the company if they are sent in without adequate testing and cover. All apologies for poor explanation.

In essence the antibody element of the testing is what Cathal has been highlighting and its importance.
We cover as the various articles in the media have highlighted the test for whether you have the virus and the check
for whether you have had the virus.

How it relates with the insurance companies may be fluid in this regard. At this stage we do not know for sure how long the antibodies last after having had the virus is it only months or a year or two. There have been arguments in this area.

The shorter it is the better for us as the need for testing people who have had the virus increases.
Companies need to test no matter what the insurance aspects. Professional firms will have highly paid professionals who if forced into the office can will their ar5e5 off them if put in unnnecessary danger.

Either way testing for firms in Finance and the Law will kick in. We are it seems going up against Honeyman group but, from what CF said, in interviews, talks with Corporates appeared fruitful. There should be plenty to go round.

I would back CF to deliver in this area. With one thousand a day you are looking at around £24 million in revenue with say around half hitting the bottom line. That alone can kick up the stock price.